Combined use of sedatives and opiates in horses.

This research explores the effects of various sedative and opiate combinations on horses, assessing their impact on vital signs and their overall suitability for clinical use.

Experiment Overview

The study was conducted on four experimental ponies. Researchers explored the effects of the following intravenous drug combinations:

• Xylazine (0.7 mg/kg) and methadone (0.1 mg/kg)
• Xylazine (0.7 mg/kg) with two different doses of buprenorphine (0.004 mg/kg and 0.006 mg/kg)
• Acepromazine (0.05 mg/kg) and buprenorphine (0.006 mg/kg)

The impact of these combinations on arterial blood pressure, central venous pressure, heart rate, respiratory rate and blood gases were studied.

Findings

On the application of both xylazine/buprenorphine and xylazine/methadone combinations, sedation in the ponies was quick and evident. While no surgical or diagnostic procedures were utilized, the level of sedation was deemed sufficient for a duration of 30 to 40 minutes.
On the other hand, the acepromazine/buprenorphine mixture brought about a slower and less noticeable onset of sedation. However, it was hard to determine how long this sedation lasted as the ponies could be awoken by noise even when they seemed fully sedated.

Implications

From the observations gathered, it was suggested that all the drug combinations, when given at the stated doses, should be safe for clinical use. This offers valuable insight for veterinary practitioners, equipping them with potentially more safe and effective sedative options for horses. However, the responsiveness of animals seemed to vary depending on the drug combination, and the onset and duration of sedation also varied. Therefore, it is essential to further understand these dynamics to apply the most suitable sedative-opioid combination in clinical scenarios.